SEK154.60
0.19%
Stockholm, Apr 17, 01:00 pm CET
ISIN
SE0011205202
Symbol
VITR
Sector
Industry

Vitrolife Stock price

SEK154.60
-22.10 12.51% 1M
-84.00 35.21% 6M
-60.40 28.09% YTD
-27.70 15.19% 1Y
-156.00 50.23% 3Y
-16.20 9.48% 5Y
+123.60 398.71% 10Y
Stockholm, Closing price Thu, Apr 17 2025
-0.30 0.19%
ISIN
SE0011205202
Symbol
VITR
Sector
Industry

Key metrics

Market capitalization SEK20.94b
Enterprise Value SEK21.89b
P/E (TTM) P/E ratio 40.81
EV/FCF (TTM) EV/FCF 26.86
EV/Sales (TTM) EV/Sales 6.07
P/S ratio (TTM) P/S ratio 5.80
P/B ratio (TTM) P/B ratio 1.54
Dividend yield 0.71%
Last dividend (FY24) SEK1.10
Revenue growth (TTM) Revenue growth 2.76%
Revenue (TTM) Revenue SEK3.61b
EBIT (operating result TTM) EBIT SEK810.00m
Free Cash Flow (TTM) Free Cash Flow SEK815.00m
Cash position SEK1.14b
EPS (TTM) EPS SEK3.79
P/E forward 33.53
P/S forward 5.58
EV/Sales forward 5.84
Show more

Is Vitrolife a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Vitrolife Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Vitrolife forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Vitrolife forecast:

Buy
80%
Hold
20%

Financial data from Vitrolife

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
3,608 3,608
3% 3%
100%
- Direct Costs 1,731 1,731
8% 8%
48%
1,877 1,877
2% 2%
52%
- Selling and Administrative Expenses 511 511
15% 15%
14%
- Research and Development Expense 115 115
8% 8%
3%
1,251 1,251
5% 5%
35%
- Depreciation and Amortization 441 441
4% 4%
12%
EBIT (Operating Income) EBIT 810 810
7% 7%
22%
Net Profit 513 513
113% 113%
14%

In millions SEK.

Don't miss a Thing! We will send you all news about Vitrolife directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. Its products and services include oocyte retrieval needles, sperm processing, IVF media and oil, micromanipulation pipettes, labware, benchtop incubators, time-lapse systems, preimplantation genetic testing, cryopreservation, laser and imaging systems, and lab quality control systems. The firm operates through the following geographical segments: Europe, Middle East, and Africa (EMEA); North and South America; Japan and Pacific; and Asia. The company was founded in 1994 and is headquartered in Gothenburg, Sweden.

Head office Sweden
CEO Bronwyn O'Connor
Employees 1,120
Founded 1989
Website www.vitrolife.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today